CSIMarket


Metagenomi Inc   (NASDAQ: MGX)
Other Ticker:  
 


 

Metagenomi Inc

MGX's Financial Statements and Analysis



Metagenomi Inc narrowed forth quarter of 2024 net loss per share of $-0.57 compare to net loss per share of $-2.36 recorded in the same quarter a year ago a decrease compare to $-0.51 realized in previous quarter.


forth quarter of 2024
Earnings Per Share Revenues
$ -0.57 $  10 Mill
$+1.79     $-43M     -81.62 %



Metagenomi Inc 's Revenue fell by -81.62 % in forth quarter of 2024 (Dec 31 2024) year on year, to $10 million and declined by -16.5 % sequentially.


Metagenomi Inc is

More on MGX's Income Statement



Metagenomi Inc in the forth quarter of 2024 recorded net loss of $-23.398 million, an improvement compare to net loss of $-78.058 million in 2024 a year ago.

Sequentially net loss advanced

More on MGX's Growth

Metagenomi Inc Inventories
MGX's Cash flow In the forth quarter of 2024 company's net cash flow was $2 million, capital expenditures grew by -3.114-89.27%, to $0 millions compare to same quarter a year ago

More on MGX's Cash flow Statement


Metagenomi Inc does not pay out common stock dividend.

In trailing twelve-month period Metagenomi Inc payed $ -3.30 cash per share, on a free-cash flow basis .

Book value grew by 2.07 % sequentially to $7.10 per share.
Tangible Book value grew to $ 7.10 per share from $ 6.96.

Company repurchased 3.69 million shares or 10.04 % in Dec 31 2024.


More on MGX's Dividends

 Market Capitalization (Millions) 51
 Shares Outstanding (Millions) 33
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 52
 Net Income (TTM) (Millions $) -78
 Cash Flow (TTM) (Millions $) -113
 Capital Exp. (TTM) (Millions $) -3
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 51




Metagenomi Inc does not pay out common stock dividend.

In trailing twelve-month period Metagenomi Inc had negative $ -3.30 cash flow per share, on a free-cash flow basis .

Book value grew by 2.07 % sequentially to $7.10 per share.
Tangible Book value grew to $ 7.10 per share from $ 6.96.

Company repurchased 3.69 million shares or 10.04 % in Dec 31 2024.


More on MGX's Balance Sheets

 Market Capitalization (Millions) 51
 Shares Outstanding (Millions) 33
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 52
 Net Income (TTM) (Millions $) -78
 Cash Flow (TTM) (Millions $) -113
 Capital Exp. (TTM) (Millions $) -3
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 51
   


  News about Metagenomi Inc Earnings